Guillain-Barre Syndrome
Neurology·MeSH: Guillain-Barre Syndrome
Prevalence
30.0 / 100K
2 drugs in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Guillain-Barre Syndrome?
BioSniper tracks 2 drugs in development for Guillain-Barre Syndrome across 1 company.
How many clinical trials target Guillain-Barre Syndrome?
There are 3 clinical trials targeting Guillain-Barre Syndrome tracked by BioSniper.
What is the prevalence of Guillain-Barre Syndrome?
The estimated prevalence of Guillain-Barre Syndrome is approximately 30.0 per 100,000 population.
Deep-dive into Guillain-Barre Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis